Nexfin Noninvasive Continuous Hemodynamic Monitoring: Validation against Continuous Pulse Contour and Intermittent Transpulmonary Thermodilution Derived Cardiac Output in Critically Ill Patients

Introduction. Nexfin (Bmeye, Amsterdam, Netherlands) is a noninvasive cardiac output (CO) monitor based on finger arterial pulse contour analysis. The aim of this study was to validate Nexfin CO (NexCO) against thermodilution (TDCO) and pulse contour CO (CCO) by PiCCO (Pulsion Medical Systems, Munic...

Full description

Saved in:
Bibliographic Details
Main Authors: Koen Ameloot, Katrijn Van De Vijver, Ole Broch, Niels Van Regenmortel, Inneke De laet, Karen Schoonheydt, Hilde Dits, Berthold Bein, Manu L. N. G. Malbrain
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2013/519080
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850221090596454400
author Koen Ameloot
Katrijn Van De Vijver
Ole Broch
Niels Van Regenmortel
Inneke De laet
Karen Schoonheydt
Hilde Dits
Berthold Bein
Manu L. N. G. Malbrain
author_facet Koen Ameloot
Katrijn Van De Vijver
Ole Broch
Niels Van Regenmortel
Inneke De laet
Karen Schoonheydt
Hilde Dits
Berthold Bein
Manu L. N. G. Malbrain
author_sort Koen Ameloot
collection DOAJ
description Introduction. Nexfin (Bmeye, Amsterdam, Netherlands) is a noninvasive cardiac output (CO) monitor based on finger arterial pulse contour analysis. The aim of this study was to validate Nexfin CO (NexCO) against thermodilution (TDCO) and pulse contour CO (CCO) by PiCCO (Pulsion Medical Systems, Munich, Germany). Patients and Methods. In a mix of critically ill patients (n=45), NexCO and CCO were measured continuously and recorded at 2-hour intervals during the 8-hour study period. TDCO was measured at 0–4–8 hrs. Results. NexCO showed a moderate to good (significant) correlation with TDCO (R2 0.68, P<0.001) and CCO (R2 0.71, P<0.001). Bland and Altman analysis comparing NexCO with TDCO revealed a bias (± limits of agreement, LA) of 0.4 ± 2.32 L/min (with 36% error) while analysis comparing NexCO with CCO showed a bias (±LA) of 0.2 ± 2.32 L/min (37% error). NexCO is able to follow changes in TDCO and CCO during the same time interval (level of concordance 89.3% and 81%). Finally, polar plot analysis showed that trending capabilities were acceptable when changes in NexCO (ΔNexCO) were compared to ΔTDCO and ΔCCO (resp., 89% and 88.9% of changes were within the level of 10% limits of agreement). Conclusion. we found a moderate to good correlation between CO measurements obtained with Nexfin and PiCCO.
format Article
id doaj-art-7426cae298c04ad984ef43d2608e52ee
institution OA Journals
issn 1537-744X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-7426cae298c04ad984ef43d2608e52ee2025-08-20T02:06:49ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/519080519080Nexfin Noninvasive Continuous Hemodynamic Monitoring: Validation against Continuous Pulse Contour and Intermittent Transpulmonary Thermodilution Derived Cardiac Output in Critically Ill PatientsKoen Ameloot0Katrijn Van De Vijver1Ole Broch2Niels Van Regenmortel3Inneke De laet4Karen Schoonheydt5Hilde Dits6Berthold Bein7Manu L. N. G. Malbrain8Department of Intensive Care Medicine, Ziekenhuis Netwerk Antwerpen, ZNA Stuivenberg, Lange Beeldekensstraat 267, 2060 Antwerp, BelgiumDepartment of Intensive Care Medicine, Ziekenhuis Netwerk Antwerpen, ZNA Stuivenberg, Lange Beeldekensstraat 267, 2060 Antwerp, BelgiumDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Schwanenweg 21, 24105 Kiel, GermanyDepartment of Intensive Care Medicine, Ziekenhuis Netwerk Antwerpen, ZNA Stuivenberg, Lange Beeldekensstraat 267, 2060 Antwerp, BelgiumDepartment of Intensive Care Medicine, Ziekenhuis Netwerk Antwerpen, ZNA Stuivenberg, Lange Beeldekensstraat 267, 2060 Antwerp, BelgiumDepartment of Intensive Care Medicine, Ziekenhuis Netwerk Antwerpen, ZNA Stuivenberg, Lange Beeldekensstraat 267, 2060 Antwerp, BelgiumDepartment of Intensive Care Medicine, Ziekenhuis Netwerk Antwerpen, ZNA Stuivenberg, Lange Beeldekensstraat 267, 2060 Antwerp, BelgiumDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Schwanenweg 21, 24105 Kiel, GermanyDepartment of Intensive Care Medicine, Ziekenhuis Netwerk Antwerpen, ZNA Stuivenberg, Lange Beeldekensstraat 267, 2060 Antwerp, BelgiumIntroduction. Nexfin (Bmeye, Amsterdam, Netherlands) is a noninvasive cardiac output (CO) monitor based on finger arterial pulse contour analysis. The aim of this study was to validate Nexfin CO (NexCO) against thermodilution (TDCO) and pulse contour CO (CCO) by PiCCO (Pulsion Medical Systems, Munich, Germany). Patients and Methods. In a mix of critically ill patients (n=45), NexCO and CCO were measured continuously and recorded at 2-hour intervals during the 8-hour study period. TDCO was measured at 0–4–8 hrs. Results. NexCO showed a moderate to good (significant) correlation with TDCO (R2 0.68, P<0.001) and CCO (R2 0.71, P<0.001). Bland and Altman analysis comparing NexCO with TDCO revealed a bias (± limits of agreement, LA) of 0.4 ± 2.32 L/min (with 36% error) while analysis comparing NexCO with CCO showed a bias (±LA) of 0.2 ± 2.32 L/min (37% error). NexCO is able to follow changes in TDCO and CCO during the same time interval (level of concordance 89.3% and 81%). Finally, polar plot analysis showed that trending capabilities were acceptable when changes in NexCO (ΔNexCO) were compared to ΔTDCO and ΔCCO (resp., 89% and 88.9% of changes were within the level of 10% limits of agreement). Conclusion. we found a moderate to good correlation between CO measurements obtained with Nexfin and PiCCO.http://dx.doi.org/10.1155/2013/519080
spellingShingle Koen Ameloot
Katrijn Van De Vijver
Ole Broch
Niels Van Regenmortel
Inneke De laet
Karen Schoonheydt
Hilde Dits
Berthold Bein
Manu L. N. G. Malbrain
Nexfin Noninvasive Continuous Hemodynamic Monitoring: Validation against Continuous Pulse Contour and Intermittent Transpulmonary Thermodilution Derived Cardiac Output in Critically Ill Patients
The Scientific World Journal
title Nexfin Noninvasive Continuous Hemodynamic Monitoring: Validation against Continuous Pulse Contour and Intermittent Transpulmonary Thermodilution Derived Cardiac Output in Critically Ill Patients
title_full Nexfin Noninvasive Continuous Hemodynamic Monitoring: Validation against Continuous Pulse Contour and Intermittent Transpulmonary Thermodilution Derived Cardiac Output in Critically Ill Patients
title_fullStr Nexfin Noninvasive Continuous Hemodynamic Monitoring: Validation against Continuous Pulse Contour and Intermittent Transpulmonary Thermodilution Derived Cardiac Output in Critically Ill Patients
title_full_unstemmed Nexfin Noninvasive Continuous Hemodynamic Monitoring: Validation against Continuous Pulse Contour and Intermittent Transpulmonary Thermodilution Derived Cardiac Output in Critically Ill Patients
title_short Nexfin Noninvasive Continuous Hemodynamic Monitoring: Validation against Continuous Pulse Contour and Intermittent Transpulmonary Thermodilution Derived Cardiac Output in Critically Ill Patients
title_sort nexfin noninvasive continuous hemodynamic monitoring validation against continuous pulse contour and intermittent transpulmonary thermodilution derived cardiac output in critically ill patients
url http://dx.doi.org/10.1155/2013/519080
work_keys_str_mv AT koenameloot nexfinnoninvasivecontinuoushemodynamicmonitoringvalidationagainstcontinuouspulsecontourandintermittenttranspulmonarythermodilutionderivedcardiacoutputincriticallyillpatients
AT katrijnvandevijver nexfinnoninvasivecontinuoushemodynamicmonitoringvalidationagainstcontinuouspulsecontourandintermittenttranspulmonarythermodilutionderivedcardiacoutputincriticallyillpatients
AT olebroch nexfinnoninvasivecontinuoushemodynamicmonitoringvalidationagainstcontinuouspulsecontourandintermittenttranspulmonarythermodilutionderivedcardiacoutputincriticallyillpatients
AT nielsvanregenmortel nexfinnoninvasivecontinuoushemodynamicmonitoringvalidationagainstcontinuouspulsecontourandintermittenttranspulmonarythermodilutionderivedcardiacoutputincriticallyillpatients
AT innekedelaet nexfinnoninvasivecontinuoushemodynamicmonitoringvalidationagainstcontinuouspulsecontourandintermittenttranspulmonarythermodilutionderivedcardiacoutputincriticallyillpatients
AT karenschoonheydt nexfinnoninvasivecontinuoushemodynamicmonitoringvalidationagainstcontinuouspulsecontourandintermittenttranspulmonarythermodilutionderivedcardiacoutputincriticallyillpatients
AT hildedits nexfinnoninvasivecontinuoushemodynamicmonitoringvalidationagainstcontinuouspulsecontourandintermittenttranspulmonarythermodilutionderivedcardiacoutputincriticallyillpatients
AT bertholdbein nexfinnoninvasivecontinuoushemodynamicmonitoringvalidationagainstcontinuouspulsecontourandintermittenttranspulmonarythermodilutionderivedcardiacoutputincriticallyillpatients
AT manulngmalbrain nexfinnoninvasivecontinuoushemodynamicmonitoringvalidationagainstcontinuouspulsecontourandintermittenttranspulmonarythermodilutionderivedcardiacoutputincriticallyillpatients